Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
InnoLak and Low-Dose Radiation in Recurrent Cervical Cancer
NCT01194609Phase 2Terminated
- Sponsor
- Korea Cancer Center Hospital
- Start
- Sep 2010
- Primary completion
- Sep 2011
- Modality
- Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of InnoLak in Cervical Cancer (CC), sponsored by Korea Cancer Center Hospital. Started Sep 2010; status: terminated.
02
Drugs
InnoLak
03
Conditions
Cervical Cancer (CC)
Beyond the preview
Go deeper on NCT01194609.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01194609.